Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery

2019/06/21 by Sean van Diepen, Rajendra H. Mehta, Jeffrey D. Leimberger +20 · 21 citations
Medicine · Engineering · #Heart Failure Treatment and Management #Mechanical Circulatory Support Devices #Cardiac Structural Anomalies and Repair

paper · pdf · doi:10.1016/j.jtcvs.2019.06.020

Citations

• THE ESTIMATION AND SIGNIFICANCE OF THE LOGARITHM OF A RATIO OF FREQUENCIES

Cited by

• Levosimendan in the light of the results of the recent randomized controlled trials: an expert opinion paper. [europepmc]
• Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use. [europepmc]
• Impact of the perioperative inotropic support in grown-up congenital heart patients undergoing cardiac surgery: a propensity score adjusted analysis. [europepmc]
• Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use. [europepmc]
• Evidence and Current Use of Levosimendan in the Treatment of Heart Failure: Filling the Gap. [europepmc]
• Prospective Study on the Postoperative Use of Levosimendan After Conventional Heart Valve Replacement. [europepmc]
• Effect of perioperative levosimendan administration on postoperative N-terminal pro-B-type natriuretic peptide concentration in patients with increased cardiovascular risk factors undergoing non-cardiac surgery: protocol for the double-blind, randomised, placebo-controlled IMPROVE trial. [europepmc]
• Levosimendan improves postoperative heart function recovery and prognosis in patients with heart disease. [europepmc]
• Preventive Impella ® Support in High-Risk Patients Undergoing Cardiac Surgery. [europepmc]
• The effects of levosimendan in patients undergoing transcatheter aortic valve replacement- a retrospective analysis. [europepmc]
• Ventriculo-arterial (un)coupling in septic shock: Impact of current and upcoming hemodynamic drugs. [europepmc]
• Leveraging Innovation to Mitigate Risk During Heart Surgery. [europepmc]
• Monitoring of Levosimendan Administration in Patients with Pulmonary Hypertension Undergoing Cardiac Surgery and Effect of Two Different Dosing Schemes on Hemodynamic and Echocardiographic Parameters. [europepmc]
• Influence of timing of Levosimendan administration on outcomes in cardiac surgery. [europepmc]
• Intravenous Levosimendan versus Inhalational Milrinone in the Management of Pulmonary Hypertension during Adult Cardiac Surgery: A Randomized Clinical Trial. [europepmc]
• Prophylactic use of inotropic agents for the prevention of low cardiac output syndrome and mortality in adults undergoing cardiac surgery. [europepmc]
• Levosimendan vs. Intra-Aortic Balloon Pump in Coronary Artery Bypass Grafting: A Meta-Analysis. [europepmc]
• Effect of levosimendan treatment in cardiac surgery: a network meta-analysis of randomized controlled trials. [europepmc]
• Levosimendán y el síndrome de bajo gasto cardiaco poscardiotomía: ¿evidencia indiscutible o mera coincidencia estadística? Levosimendan and postcardiotomy low cardiac output syndrome: indisputable evidence or mere statistical coincidence? [europepmc]
• Levosimendan in Cardiogenic Shock: A Review of Mechanisms, Clinical Evidence, and Therapeutic Use [europepmc]
• Prophylactic use of inotropic agents for the prevention of low cardiac output syndrome and mortality in adults undergoing cardiac surgery [europepmc]